Amrize (NYSE:AMRZ) Sets New 1-Year Low Following Analyst Downgrade

Amrize Ltd (NYSE:AMRZ) shares reached a new 52-week low during trading on Monday after Oppenheimer lowered their price target on the stock from $62.00 to $55.00. Oppenheimer currently has an outperform rating on the stock. Amrize traded as low as $37.38 and last traded at $38.1590, with a volume of 6161890 shares changing hands. The stock had previously closed at $37.54.

AMRZ has been the subject of a number of other reports. DA Davidson initiated coverage on shares of Amrize in a report on Monday, August 24th. They issued a “neutral” rating and a $50.00 target price for the company. Weiss Ratings lowered Amrize from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, August 31st. Wells Fargo & Company reissued an “equal weight” rating and set a $44.00 price target (down from $55.00) on shares of Amrize in a research report on Wednesday, September 9th. JPMorgan Chase & Co. cut Amrize from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $57.00 to $52.00 in a research note on Wednesday, September 2nd. Finally, Royal Bank Of Canada downgraded shares of Amrize from a “sector perform” rating to an “underperform” rating and decreased their price objective for the stock from $60.00 to $48.00 in a report on Monday, August 10th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, eight have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $54.25.

Insider Buying and Selling at Amrize

In other news, Director Jacques Sanche purchased 4,150 shares of Amrize stock in a transaction dated Wednesday, August 26th. The stock was acquired at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the acquisition, the director directly owned 9,766 shares in the company, valued at $439,665.32. This represents a 73.90% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Jaime Hill purchased 1,500 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was purchased at an average cost of $47.12 per share, with a total value of $70,680.00. Following the purchase, the insider owned 29,698 shares in the company, valued at $1,399,369.76. This represents a 5.32% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought 48,983 shares of company stock valued at $2,158,755 in the last quarter. Corporate insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Norges Bank acquired a new stake in shares of Amrize during the 4th quarter worth approximately $929,333,000. Barclays PLC boosted its position in shares of Amrize by 95.4% during the 4th quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock valued at $249,557,000 after acquiring an additional 2,253,431 shares in the last quarter. National Pension Service acquired a new stake in shares of Amrize during the 4th quarter valued at about $87,784,000. DJE Kapital AG increased its stake in Amrize by 2,005.4% in the fourth quarter. DJE Kapital AG now owns 762,887 shares of the company’s stock valued at $41,986,000 after acquiring an additional 726,652 shares during the period. Finally, First Manhattan CO. LLC. increased its stake in Amrize by 20.0% in the fourth quarter. First Manhattan CO. LLC. now owns 4,036,704 shares of the company’s stock valued at $218,305,000 after acquiring an additional 672,030 shares during the period.

Amrize Price Performance

The stock has a market cap of $21.13 billion, a price-to-earnings ratio of 17.58, a price-to-earnings-growth ratio of 1.16 and a beta of 0.04. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33. The company’s 50-day moving average is $45.98 and its 200-day moving average is $51.55.

Amrize (NYSE:AMRZ) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The company had revenue of $3.49 billion during the quarter. Equities research analysts expect that Amrize Ltd will post 2.57 earnings per share for the current fiscal year.

Amrize Announces Dividend

The business also recently disclosed a dividend, which was paid on Wednesday, August 26th. Shareholders of record on Tuesday, August 18th were issued a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s dividend payout ratio (DPR) is presently 20.28%.

Amrize Company Profile

Amrize is a North American building materials and solutions company formed through the separation of Holcim’s North American business. The company began trading publicly on the New York Stock Exchange in 2025 under the symbol AMRZ.

Amrize supplies essential construction materials, including cement, aggregates, ready-mix concrete and asphalt. It also provides a range of building products and solutions used in residential, commercial and infrastructure construction, including concrete products, roofing systems and other materials designed to support building and construction projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution operations and local businesses.